Grifols (GRFS) EBITDA (2010 - 2020)
Grifols (GRFS) reported EBITDA of $1.0 billion for Q1 2020, up 7.09% on a YoY basis from $937.7 million in Q2 2019, and down 65.5% quarter-over-quarter from $2.9 billion in Q4 2019.
Grifols (GRFS) EBITDA (2010 - 2020) Analysis & Trends
Grifols has reported EBITDA for 10 years, with the latest figure at $1.0 billion in Q1 2020.
- For the quarter ending Q1 2020, EBITDA rose 7.09% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2020 stood at $7.5 billion (up 76.55% YoY), and the FY2025 full-year result was $1.4 billion, up 13.59% from the prior year.
- EBITDA for Q1 2020 stood at $1.0 billion, down from $2.9 billion in the prior quarter.
- The five-year high for EBITDA was $2.9 billion in Q4 2019, with the low at -$1.3 billion in Q4 2016.
- Historically, EBITDA has averaged $865.0 million across 5 years, with a median of $344.0 million in 2017.
- Annual changes were most pronounced in 2016 — EBITDA tumbled 236.58% — and 2017, when it soared 326.42%.
- Grifols' EBITDA stood at -$1.3 billion in 2016, then soared by 326.42% to $2.9 billion in 2017, then decreased by 10.0% to $2.6 billion in 2018, then increased by 11.36% to $2.9 billion in 2019, then tumbled by 65.5% to $1.0 billion in 2020.
- The last three EBITDA figures came in at $1.0 billion (Q1 2020), $2.9 billion (Q4 2019), and $937.7 million (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 3.09 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 9.50 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 6.36 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 3.99 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -7.73 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 2.67 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 2.59 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | -6.71 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 2.83 Bn |
| 10 | Grifols | 6.05 Bn | 5.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.00 Bn |
| Dec 31, 2019 | 2.91 Bn |
| Mar 31, 2019 | 937.75 Mn |
| Dec 31, 2018 | 2.61 Bn |
| Jun 30, 2018 | 312.31 Mn |
| Mar 31, 2018 | 365.37 Mn |
| Dec 31, 2017 | 2.90 Bn |
| Jun 30, 2017 | 313.51 Mn |
| Mar 31, 2017 | 344.02 Mn |
| Dec 31, 2016 | -1.28 Bn |
| Sep 30, 2016 | 267.29 Mn |
| Jun 30, 2016 | 242.13 Mn |
| Mar 31, 2016 | 311.60 Mn |
| Dec 31, 2015 | 939.15 Mn |
| Sep 30, 2015 | 275.09 Mn |
| Jun 30, 2015 | 262.80 Mn |
| Mar 31, 2015 | 316.35 Mn |
| Sep 30, 2013 | 246.55 Mn |
| Jun 30, 2013 | 251.96 Mn |
| Mar 31, 2013 | 247.44 Mn |